Medivation, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medivation with three other
companies in this sector in the United States:
Biomarin Pharmaceutical Inc
sales of $889.90 million
of which 34%
of which 94%
was Prescription Pharmaceuticals), and
of which 100%
was Buprenorphine Based Drugs).
Medivation reported sales of $943.26 million
December of 2015.
increase of 32.8%
versus 2014, when the company's sales were $710.49 million.
This was the fourth straight year of sales growth at Medivation.